About us

Our Vision

Making patients’ lives safer and more livable

Our Mission

We redefine drug delivery by replacing injections with oral formulations to increase patient compliance and provide save medication around the world

status quo

NovoArc GmbH was founded in October 2021 and we are currently expanding our product portfolio

The NovoArc Team

We are a team of highly motivated scientists with entrepreneurial spirit.

Teamspirit is essential for NovoArc. Each and everyone of the team members has their own assets which are vital for our success. 

If you want to be part of the Team contact us!

Dr. David
Wurm

CEO

David Wurm is a process engineer and has a PhD in the field of biotechnology. For more than 5 years he is doing project management and is responsible for the communication with industrial partners, for the coordination of the team and for keeping deadlines.
Because of his trainings in the field of business development, management and law David is CEO and co-founder of NovoArc GmbH.


Dr. Julian
Quehenberger

CTO

In his PhD Thesis Dr. Julian Quehenberger investigated biotechnological applications of extremophilic microorganisms. In the last few years he was able to develop the underlying technology which is necessary to replace injection with pills. Globally he is probably the only person who can produce the necessary lipids at the needed quality and quantity. Because of his huge knowledge in this field and his spirit of innovation Julian is CTO and co-founder of NovoArc GmbH.

Prof. Oliver
Spadiut

scientific advisor

Oliver Spadiut is Professor in Biotechnology and well known in this field. His scientific competence (>100 publications) and connections to the biotech industry (80% industry-oriented projects in cooperation with major pharmaceutical companies) allow him to give crucial scientific input.

Oliver is scientific advisor and co-founder of NovoArc GmbH.


Christina
Horn, BSc.

Scientist
Liposome Formulation

Christina focused on Liposome Formulation during her master thesis at Medical University Graz. With the gained knowledge she is a great asset to the NovoArc Team. Her main focus is the formulation of Archaeosomes with different active pharmaceutical ingredients.

Matthias
Pichler, BSc.

Scientist
Lipid Production

Matthias studied Biotechnology and Bioengineering at TU Wien. During his studies he already joined the workinggroup of the founderteam and has gathered a lot of expertise in lipid production and purification. Matthias is a creative mind and loves implementing innovative technologies.

Introducing our Advisors

All this would not be possible without the support from experts in the field. We highly appreciate the help from our advisory board.

Klara Brandstätter

CEO at I.E.C.T. Hermann Hauser Managment GmbH

Dr. Sylvia Nanz

Medical Director at Pfizer

Supported by